Harmony Biosciences Holdings Inc (HRMY)
34.07
+0.84
(+2.53%)
USD |
NASDAQ |
Nov 22, 16:00
34.07
0.00 (0.00%)
After-Hours: 20:00
Harmony Biosciences Holdings Profit Margin (Quarterly): 24.78% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 24.78% |
| June 30, 2024 | 6.71% |
| March 31, 2024 | 24.79% |
| December 31, 2023 | 15.80% |
| September 30, 2023 | 24.00% |
| June 30, 2023 | 25.56% |
| March 31, 2023 | 24.75% |
| December 31, 2022 | 37.81% |
| September 30, 2022 | 75.03% |
| June 30, 2022 | 21.99% |
| Date | Value |
|---|---|
| March 31, 2022 | 25.18% |
| December 31, 2021 | 24.90% |
| September 30, 2021 | -11.92% |
| June 30, 2021 | 19.12% |
| March 31, 2021 | 12.38% |
| December 31, 2020 | -0.37% |
| September 30, 2020 | 4.19% |
| June 30, 2020 | -0.07% |
| March 31, 2020 | -194.7% |
| December 31, 2019 | -607.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-607.8%
Minimum
Dec 2019
75.03%
Maximum
Sep 2022
-22.39%
Average
20.55%
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 36.03% |
| Incyte Corp | 9.36% |
| EyePoint Pharmaceuticals Inc | -279.0% |
| Cassava Sciences Inc | -- |
| Capricor Therapeutics Inc | -555.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 23.59% |
| Return on Assets | 14.52% |
| Return on Invested Capital | 17.28% |
| Gross Profit Margin (Quarterly) | 77.01% |
| Operating Margin (Quarterly) | 33.17% |
| Return on Net Operating Assets | 53.56% |